• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

arzerra (ofatumumab) - Articles and news items

FDA approves Genmab’s ofatumumab for relapsed CLL

Industry news / 31 August 2016 / Niamh Louise Marriott, Digital Content Producer

Approval is supported by the Phase III complement study that evaluated ofatumumab in combination with FC versus FC alone in patients with relapsed CLL…